With 2022 coming to an end, it is with great pride that we are reporting another successful year in supporting cancer research in Victoria, Australia and globally. We would like to thank the continued support of the community and the ongoing efforts of researchers in the journey to improve cancer outcomes. Please find our annual report of key achievements and some successful case studies relating to our contributions. View our Annual Key Achievements in FY 2021-22 here.
The Victorian Cancer Biobank continues to strive to deliver our high-quality services and play our part to facilitate cancer research despite the challenges caused by the COVID-19 pandemic throughout the 2020-2021 year. View our Annual Key Achievements in FY 2020-21 here. We look forward to another year of success and improving cancer outcomes.
The Victorian Cancer Biobank, one of the largest cancer biobanks in Australia, has received $6 million in funding by the Victorian Government through the Victorian Cancer Agency to continue its vital work over the next three years in collecting biospecimens of cancer tissue and blood and clinical data for research studies and clinical trials, it was announced today. With more than 450,000 biospecimens, the Victorian Cancer Biobank has supported more than 300 research projects since its inception in 2006, and thanks to this funding, will continue to facilitate scientific research and
We would like to congratulate Professor Melissa Southey, on being awarded the Order of Australia Medal in recognition of her contributions to epidemiology and precision medicine. We are fortunate to have Professor Southey as the chair of our Strategic Advisory Group, who has been invaluable in leading the strategic direction and priorities of the VCB. Professor Southey has made immensely valuable contributions to diagnostic and research settings in Australia and internationally, with a particular focus on the common cancers utilising PEDIGREE's mature population-based studies and the application of new genetic technologies. We are